Brain Shuttle Neprilysin reduces central Amyloid-β levels

• Christopher R. Campos ,

  Contributed equally to this work with: Christopher R. Campos, Alicia M. Kemble

  Roles Methodology, Validation

  Affiliation Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland

  ⨯
• Alicia M. Kemble ,

  Contributed equally to this work with: Christopher R. Campos, Alicia M. Kemble

  Roles Formal analysis, Software, Validation, Visualization, Writing – review & editing

  Affiliation Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland

  ⨯
• Jens Niewoehner,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Large Molecule Research, Roche Pharma Research and Early Development, Roche Innovation Center Munich, Munich, Germany

  ⨯
• Per-Ola Freskgård,

  Roles Funding acquisition, Resources, Supervision, Writing – review & editing

  Affiliation Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland

  ⨯
• Eduard Urich

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: eduard.urich@roche.com

  Affiliation Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland

  http://orcid.org/0000-0003-0238-5517

  ⨯